11:30 AM EDT, 07/16/2024 (MT Newswires) -- DarioHealth ( DRIO ) said Tuesday it secured a new contract to provide its cardiometabolic solution to the employees of a national employer in the environmental services sector starting in Q3.

No financial details were disclosed, nor was the name of the national employer.

DarioHealth ( DRIO ) said its cardiometabolic solution is intended to address health conditions and weight management needs, and also covers support for employees taking GLP-1 medication.

Shares of DarioHealth ( DRIO ) were down nearly 5% in recent trading.

Price: 1.38, Change: -0.07, Percent Change: -4.83